nPredictability of Recalcitrance in Neovascular Age-Related Macular Degeneration With Indocyanine Green Angiography

被引:2
|
作者
Rush, Ryan B. [1 ]
Rush, Sloan W. [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Surg, 7411 Wallace Blvd, Amarillo, TX 79106 USA
来源
关键词
indocyanine green angiography; macular degeneration; recalcitrance;
D O I
10.1097/APO.0000000000000111
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: This study aimed to evaluate the utility of indocyanine green (ICG) angiography in predicting recalcitrance in neovascular age-related macular degeneration (nAMD). Design: A retrospective case series. Methods: The charts of treatment-naive subjects with nAMD undergoing antiYvascular endothelial growth factor (anti-VEGF) therapy during a 6-month period were retrospectively reviewed. The study group consisted of subjects with persistent retinal edema on optical coherence tomography (OCT) despite 6 consecutive monthly anti-VEGF injections. The control group was age-matched to the study group and consisted of subjects who demonstrated complete resolution of retinal edema on OCT after 3 or fewer monthly anti-VEGF injections. Results: There were 42 study cases and 42 controls included in the analysis. The baseline visual acuity, central macular thickness on OCT, and choroidal neovascularization (CNV) surface area on ICG angiography were statistically similar between the study and control groups. The CNV surface area on ICG angiography 2 months after starting consecutive monthly anti-VEGF injections increased from a baseline of 1.78 +/- 0.86 to 2.66 +/- 0.92 mm(2) in the study group (P = 0.008) and decreased from a baseline of 1.94 +/- 0.97 to 1.12 +/- 0.05 mm2 in the control group (P = 0.04); this change in CNV size on ICG angiography from baseline to 2-month follow-up was statistically significant between the study and control groups (P < 0.0001). Conclusions: Change in CNV surface area on ICG angiography can predict which subjects with nAMD are likely to have persistent retinal edema on OCTafter 6 or more consecutive monthly anti-VEGF injections.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [41] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [42] Pegaptanib for neovascular age-related macular degeneration
    Gragoudas, ES
    Adamis, AP
    Cunningham, ET
    Feinsod, M
    Guyer, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27): : 2805 - 2816
  • [43] Management of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Pruente, Christian
    PROGRESS IN RETINAL AND EYE RESEARCH, 2007, 26 (04) : 437 - 451
  • [44] Imaging in Neovascular Age-Related Macular Degeneration
    Gess, Adam J.
    Fung, Anne E.
    Rodriguez, Jorge G.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 225 - 233
  • [45] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [46] Radiotherapy for neovascular age-related macular degeneration
    Evans, Jennifer R.
    Sivagnanavel, Vasuki
    Chong, Victor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [47] Bevacizumab for Neovascular Age-Related Macular Degeneration
    Silva, Aline
    Furlan, Luiz
    Elias, Flavia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 75 - 76
  • [48] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [49] β-blockers and Neovascular Age-related Macular Degeneration
    Yeung, Ling
    Huang, Ting-Shuo
    Lin, Yun-Hsuan
    Hsu, Kuang-Hung
    Huang, Jerry Chien-Chieh
    Sun, Chi-Chin
    OPHTHALMOLOGY, 2017, 124 (03) : 409 - 411
  • [50] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466